The global surgical navigation systems market is anticipated to reach market size of around US$ 2,000 Mn by 2027 and is anticipated to grow at a CAGR of around 6% in terms of revenue during the forecast period 2020 – 2027.
Asthma is a disease inflammatory in the lung, which makes it impossible to breathe. MIC is normal because of minor incisions, decreased discomfort and a short healing duration. The procedure is minimally invasive. Operational navigation devices of neurosurgery, orthopaedic surgery etc. was commonly introduced to improve MIS protection and precision. Computers are used for preoperative preparation, intraoperative instructions and surgery.
The global market for operating systems is driven by the increasing number of neurological, orthopaedic and Ear, Nose and Throat (ENT) procedures, increased desire for minimally invasive surgery and increased product releases and approvals. However, the growth in this market during the forecast period is expected to be hindered by strict regulatory policies and product recalls. But in developing markets the development outlook is set to be a lucrative prospect for business growth in the near future.
The highest share of sales in North America was in 2019. Regional development is expected to be driven by the growing prevalence of orthopaedic, ENT and neurological disorders. Consequently, increased patient volume raises demand for operating systems, boosting geographic demand for operating systems. This increases the number of patients. The biggest growth driver in hospitals is the increased preference for ambulatory hospitals and, along with rising operating volumes. The regional demand is driven by a quality-driven health paradigm paired with an emphasis on ambulatory surgery in a cost-curbing environment. Factor that lead to growth of global revenue are responsible for overall regional business growth, for instance, the growing geriatric population and a well defined reimbursement structure. The growth of Asia Pacific over the projected period is forecast to be exponential. Developing nations, increasing ageing population and growing health care understanding can be attributed to the fastest growth rate of the regional sector. This makes the geriatric population more likely to have orthopaedic diseases, and in the field, Japan, China and India are the main contributors. In addition, the growth is expected to boost untapped opportunities, increased interest by companies in expanding their footprint in this area, and continued R&D activities by key players in improving innovative goods. In April 2018 , for example, B. In order to extend the production of medicinal solutions, infusion therapy medical equipment and chirurgical instruments, Braun opened five new production plants in Malaysia.
Stringent Rules & Regulations for Product Approval and Product Recall in the Past
Surgical navigation systems are designed to direct surgeons to conduct exact operations. Any errors can affect the health of the patient and endanger his or her life. Consequently, a regulatory approval process is obligatory for each new product to conform with the specifications of the class II categories of medical equipment. This is a very rigorous and time intensive method of product clearance. Moreover, owing to strict legislation, various products have been reminiscent in recent history of the image-oriented operating products industry due to their inaccuracy in anatomy showing. For instance, in January 2016, Brainlab recalled its Cranial Image Controlled Surgery (IGS), which provided inconsistent and different show findings in relation to patient anatomy. X-NAV Technologies, LLC, similarly reminisced in February 2016 of the X-Guide Surgical Navigation System.
Some of the prominent players in the surgical navigation systems market include Brainlab, B. Braun Melsungen AG, DePuy Synthes, Ilumark GmbH, Scopis GmbH, Medtronic plc, Siemens Healthineers, Stryker Corporation, Smith & Nephew, Zimmer Biomet, and others. Their presence in several parts of the surgical navigation systems reveals considerable geographical protection. Method and partnership and innovative product creation techniques are adopted by suppliers for the unmet criteria of a significant portion of the patients with psychiatric, orthopaedic and ENT disease. Fiagon AG, Brainlab AG, and Amplitude Surgical are other major players in the global surgical navigation device market.
The global surgical navigation systems market is segmented as below:
Surgical Navigation Systems Market By Technology
Electromagnetic Navigation Systems
Hybrid Navigation Systems
Optical Navigation Systems
Fluoroscopy-Based Navigation Systems
CT-Based Navigation Systems
Surgical Navigation Systems Market By Application
Neurosurgery Navigation Systems
Orthopedic Navigation Systems
ENT Navigation Systems
Dental Navigation Systems
Cardiac Navigation Systems
Surgical Navigation Systems Market By End User
Physician Practices & Ambulatory Settings
Surgical Navigation Systems Market By Geography
Middle East & Africa
The market for surgical navigation systems is expected to reach a market value of around US$ 2,000 Mn by 2027.
The surgical navigation systems market is expected to grow at a CAGR of around 6% from 2020 to 2027.
The hospital is the leading segment by end user in the surgical navigation systems market.
Technological advancements in surgical navigation systems result in added features, higher success rate, and newer application of the device depending on its usage in various surgical procedures.
Brainlab, B. Braun Melsungen AG, DePuy Synthes, Ilumark GmbH, Scopis GmbH, Medtronic plc, Siemens Healthineers, Stryker Corporation, Smith & Nephew, Zimmer Biomet, and others are the prominent players in the market.
North America held the highest market share in the surgical navigation systems market.
Asia Pacific is expected to be the fastest growing market over the forecast period.